J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...
Daily Mail on MSN

Hope for thousands as new drug cuts prostate cancer relapse risk by a third

Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the ...

Prostate cancer breakthrough as new drug combo gives high-risk patients a powerful new chance

Data from a late-stage trial, presented on Sunday, indicate that the treatment, administered six months before and after ...
FiercePharma

ASCO: J&J breaks the prostate cancer treatment mold with fresh Erleada ph. 3 win

With a new phase 3 win for Erleada (apalutamide), Johnson & Johnson is proposing a solution to a longstanding prostate cancer treatment gap. For patients with high-risk localized or locally advanced ...
AOL

Intimacy after prostate removal: What to expect & how to adjust

Can you have intimacy after prostate removal? Yes. It just might feel a little different. Recovery takes time, and everyone heals at their own pace. Some changes in intimate function are common after ...

J&J drug Erleada reduces risk of prostate cancer spread, death

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...